摘要
目的探讨轻型颅脑损伤(mild traumatic brain injury,mTBI)后患者血清泛素C末端水解酶L1(ubiquitin C-terminal hydrolase-L1,UCH-L1)含量的临床意义和患者预后关系。方法用ELISA法检测56例轻型颅脑损伤患者血清UCH-L1含量并与30例体检健康患者比较。对比27例头颅CT阴性和29例头颅CT阳性mTBI患者血清UCH-L1含量。评估患者6个月后GOS-E评分和mTBI患者血清UCH-L1含量的关系。结果轻型颅脑损伤患者血清UCH-L1含量显著高于正常对照组(P<0.05)。mTBI后头颅CT阳性和阴性患者血清UCH-L1含量比较有统计学意义,血清UCH-L1含量在鉴别mTBI患者时有较高的敏感度(82.8%)和特异性(70.4%)。血清UCH-L1含量越高患者预后越差,但其不能单独作为头颅CT阴性患者预后判断指标。结论 UCH-L1可作为轻型颅脑损伤诊断的生物标志物,并有较高的特异性和敏感度。血清UCH-L1含量越高患者预后越差,但UCH-L1不能单独判断头颅CT阴性mTBI患者预后。
Objective To explore the clinical significance of serum ubiquitin C-terminal hydrolase-L1 (UCH-L1) change in patients after mild traumatic brain injury (mTBI),and the relationship between UCH-L1 and prognosis.Methods Serum UCH-L1 content was detected by ELISA and Comparative Study in 56 cases of mild head injury patients and 30 healthy subjects was perpormed.The serum concentrations of UCH-L1 was compared between the 27 cases of cranial CT negative patients after mTBI and the 29 cases of cranial CT positive patients after mTBI.The relationship was assessed between the GOS-E score of patient after 6 months and UCH-L1.Results The serum concentrations of UCH-L1 between patients and the control group was statistically significant (P < 0.05).The serum UCH-L1 concentration between the patients with cranial CT positive and those with cranial CT negative was statistically significant.It had high sensitivity(82.8%) and specificity(70.4%) to discriminate between the patients with cranial CT positive and those with cranial CT negative by the serum UCH-L1 concentration.The higher the concentration of serum UCH-L1,the worse the prognosis,but it is not a prognostic indicator in cranial CT negative patients.Conclusion Serum concentrations of UCH-L1 can be used as mTBI diagnostic biomarkers,and have high specificity and sensitivity.The higher the concentration of serum UCH-L1,the worse the prognosis,but UCH -L1 can not determine the prognosis of patients with head CT negative.
出处
《医学研究杂志》
2014年第7期116-118,共3页
Journal of Medical Research